Abraham M. Siika
Eldoret, Kenya
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial.
Journal: The lancet. HIV
Published: September 03, 2025
Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa.
Journal: Contemporary clinical trials
Published: August 21, 2025
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial.
Journal: Nature medicine
Published: June 25, 2025
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Journal: Contemporary clinical trials
Published: January 27, 2025
Global Equity in Clinical Trials: A Pragmatic Approach.
Journal: JCO global oncology
Published: January 21, 2025
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial.
Journal: The Lancet. Infectious diseases
Published: March 17, 2024
Post-intervention perceptions on the antiretroviral therapy community group model in Trans Nzoia County, Kenya.
Journal: The Pan African medical journal
Published: September 29, 2023
Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa.
Journal: Nature communications
Published: May 15, 2023
Assessing HIV-infected patient retention in a program of differentiated care in sub-Saharan Africa: a G-estimation approach.
Journal: The international journal of biostatistics
Published: February 17, 2023
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial.
Journal: EClinicalMedicine
Published: November 09, 2022
Types and Outcomes of Arrhythmias in a Cardiac Care Unit in Western Kenya: A Prospective Study.
Journal: Global heart
Published: September 01, 2022
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.
Journal: The lancet. HIV
Published: March 07, 2022
Last Updated: 09/26/2026